Pirkko Härkönen (Former)
21 – 30 of 60
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2008
-
Mark
Estrogen and the selective estrogen receptor modulator (SERM) protection against cell death in estrogen receptor alpha and beta expressing U2OS cells
(
- Contribution to journal › Article
-
Mark
Alendronate decreases orthotopic PC-3 prostate tumor growth and metastasis to prostate-draining lymph nodes in nude mice
(
- Contribution to journal › Article
-
Mark
The Wnt-5a-derived hexapeptide Foxy-5 inhibits breast cancer metastasis in vivo by targeting cell motility.
(
- Contribution to journal › Article
-
Mark
Multiple cellular mechanisms related to cyclin A1 in prostate cancer invasion and metastasis.
(
- Contribution to journal › Article
-
Mark
Editorial Comment on: Expression and Prognostic Relevance of Annexin A3 in Prostate Cancer.
2008) In European Urology(
- Contribution to journal › Article
- 2007
-
Mark
Quantitative detection of cell surface protein expression by time-resolved fluorimetry
(
- Contribution to journal › Article
-
Mark
Role of fibroblast growth factor 8 in growth and progression of hormonal cancer
(
- Contribution to journal › Scientific review
-
Mark
A highly conserved protein secreted by the prostate cancer cell line PC-3 is expressed in benign and malignant prostate tissue.
(
- Contribution to journal › Article
-
Mark
Tamoxifen-induced Rapid Death of MCF-7 Breast Cancer Cells is mediated via ERK Signaling and can be abrogated by Estrogen.
(
- Contribution to journal › Article
-
Mark
Differential effects of selective oestrogen receptor modulators (SERMs) tamoxifen, ospemifene and raloxifene on human osteoclasts in vitro
(
- Contribution to journal › Article